Toradol (Ketorolac) 10 mg Tablets: Potent Prescription NSAID for Short-Term Acute Moderate-to-Severe Pain Relief

Information last reviewed: May 2026 — for educational purposes only.

Toradol (ketorolac tromethamine) is a prescription NSAID notable for providing opioid-comparable analgesia without opioid side effects or dependence potential. It is available as 10 mg oral tablets and as an injectable solution (intramuscular or intravenous). The oral tablet form is strictly intended for short-term pain management — no more than 5 consecutive days — and is typically prescribed as step-down therapy following initial IM/IV ketorolac administered in a clinical setting such as an emergency department or post-surgical recovery unit.

What Is Ketorolac (Toradol)?

Ketorolac is a pyrrolizine carboxylic acid derivative and potent non-selective COX inhibitor. Its analgesic potency by weight is among the highest of all oral NSAIDs — the 10 mg oral dose can match the analgesic effect of moderate opioid doses for acute pain conditions such as renal colic, migraine, musculoskeletal trauma, and post-operative pain. Unlike opioids, ketorolac does not cause respiratory depression, but it carries significant GI, renal, and cardiovascular risks that limit its use to the short term.

The drug reached widespread use in the 1990s partly because emergency physicians recognised that IV/IM ketorolac offered opioid-sparing pain control. This reduces opioid exposure in settings where opioid administration carries risk (e.g., patients with obstructive sleep apnoea, patients requiring rapid discharge after surgery).

Prescription-Only: No OTC Ketorolac

Ketorolac is prescription-only in all formulations. It is not available OTC and cannot be used for chronic pain management. The FDA mandates a strict 5-day cumulative limit on ketorolac use (combining days of oral and injectable treatment). Physicians are required to consider renal function before prescribing, as ketorolac can cause acute tubular necrosis with even a short course in patients with marginal kidney function.

Available Strengths and Dosage Forms

• 10 mg oral tablets — typical adult dose: 20 mg as loading dose, then 10 mg every 4–6 hours; max 40 mg/day orally; max 5 days total (oral + injectable combined)
• 15 mg/mL and 30 mg/mL injection solution (IM/IV) — initial hospital or clinic dose: 30 mg IM or 15–30 mg IV; 15 mg in elderly patients or those <50 kg
• Nasal spray (Sprix) 15.75 mg/spray — each nostril delivers 15.75 mg; approved for short-term moderate-to-moderately-severe pain in adults where oral use is not feasible

In the elderly (≥65 years) and in patients weighing under 50 kg, doses are reduced by half to limit accumulation and toxicity risk. Ketorolac is contraindicated in patients with peptic ulcer disease, advanced renal failure, or prior GI bleeding, and in patients taking other NSAIDs, anticoagulants (unless benefits clearly outweigh risks), or aspirin.

Price of Ketorolac Tablets

Generic ketorolac 10 mg tablets are relatively inexpensive at US pharmacies. A 20-count supply (a 5-day course at 40 mg/day divided doses) is very affordable even without insurance. The injectable solution for clinical use is also available as a generic at low cost. Brand-name Toradol is no longer commercially available in the US; all formulations are generic.

Frequently Asked Questions

Why is ketorolac limited to only 5 days?

Ketorolac's potent COX-1 inhibition means that even short-term use significantly suppresses prostaglandins that protect the gastric mucosa and maintain renal perfusion. Clinical experience and FDA post-marketing surveillance revealed serious GI bleeds, peptic ulceration, and acute renal failure with prolonged use. The 5-day limit was established to provide adequate acute pain coverage while preventing cumulative toxicity that becomes substantially more likely beyond one week of use.

How is Toradol different from other NSAIDs for acute pain?

Ketorolac's unusually high analgesic potency distinguishes it from ibuprofen or naproxen for severe acute pain. Its parenteral form allows use when patients cannot take oral medications, and its opioid-sparing effect is clinically valuable in multimodal post-operative pain protocols. It is not suitable for chronic conditions — for chronic pain, lower-risk NSAIDs or disease-modifying therapies are preferred.

← Back to Pain Relief Medications